series-c-plus
Stage
1
Investors
About
Triveni Bio is a clinical-stage biotechnology company developing first-in-class bispecific antibody therapeutics using a genetics-informed approach to treat immune and inflammatory diseases, including atopic dermatitis.
Explore Triveni Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.